Adventis Health adds new recruits
September 10, 2010Medical Communications Adventis, appointment, medical communications
Beaconsfield, UK-based healthcare communications agency Adventis Health has added two more recruits to its multi-disciplinary teams. Dan Blomfield (pictured left), …
GSK paves way for biopharmaceuticals growth
September 9, 2010Research and Development GlaxoSmithKline, Lonza, biologics
GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
Universities attack European research grant
September 9, 2010Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia
A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …
EU set to pass stricter laws for experiments on animals
September 9, 2010Research and Development Animal testing, Animal tests
The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …
Tzvi Palash joins Protalix BioTherapeutics
September 9, 2010Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development
Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
J&J and Merck heading for showdown over drug rights
September 8, 2010Sales and Marketing Johnson & Johnson, Merck, Remicade
Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …
inVentiv Health acquires French advertising group
September 8, 2010Medical Communications France, advertising, inVentiv Health
InVentiv Health is to acquire Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. …
Pharma sector optimism growing
September 8, 2010Sales and Marketing Eversheds, economic climate
Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …
Greece to cut 4,000 drug prices by a fifth
September 8, 2010Sales and Marketing Greece, economic climate, price cuts, pricing & Reimbursement
The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …
BMS to acquire ZymoGenetics
September 8, 2010Research and Development, Sales and Marketing BMS, hepatitis
Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
GSK patient recruitment head joins Exco InTouch
September 8, 2010Research and Development Exco InTouch, appointment, research and development
Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …
Working Life: Dr Meena Jain
September 8, 2010Business Services, Research and Development Napp, Working Life, careers, recruitment
How did you find your way into your most current role? I’ve been at Napp for four years now having …
PCT managers have ‘no automatic right’ to GP commissioning
September 8, 2010GP, NHS, commissioning, government
Primary care trust managers should not have a legal right to transfer to similar roles in GP commissioning groups, according …
Pfizer drops brain cancer vaccine
September 7, 2010Research and Development Celldex Therapeutics, Pfizer, cancer vaccine
Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
Roche signs Alzheimer’s deal with reMYND
September 7, 2010Research and Development Alzheimer's, Parkinson's, Roche, reMYND
Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Merck averts day in court over Dutch plant closure
September 7, 2010Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts
Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …
FDA cites another Sun Pharma unit for GMP violations
September 7, 2010Manufacturing and Production Sun Pharma, manufacturing compliance
Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …
Pharma manufacturing news in brief
September 7, 2010Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
Stephen Stamp joins board at Eusa Pharma
September 7, 2010Sales and Marketing Eusa Pharma, appointment, sales and marketing
Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …
Russian API manufacturer eyes IPO and acquisitions
September 7, 2010Manufacturing and Production API, Pharmsynthez, Russia
Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
